Story thread · 2 reports / 2 sources

Thyroid Drug Recall Most Serious; GLP-1s and Vitamin Deficiency; New T1D Guidelines

medpagetoday.com · 4h

How the coverage leans

Across 2 sources · syndicated copies counted once

(MedPage Today) -- The FDA designated Vitruvias Therapeutics' recall of a lot of 30-mg levothyroxine-liothyronine tablets (Thyroid Tablets) as Class I, its most serious classification. (USA Today) At least six major U.S. hospitals have shut down...

First report: FDA issues recall of thyroid medication citing ‘super potency’ — kiro7.com, 1d

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.